Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Knight, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Leukemia/bmt Program of Bcdiv of Hem, Vancouver Gen Hosp
Vancouver, British Columbia, Canada
- Dalhousie University Queen Elizabeth Ii Health Services Centre
Halifax, Nova Scotia, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Mcgill University
Montreal, Quebec, Canada
- Mayo Clinic
Scottsdale, Arizona, United States
- Alta Bates Cancer Center
Berkeley, California, United States
- Scripps Cancer Center
La Jolla, California, United States
- Cedar Sinai Medical Centerdept of Medicine
Los Angeles, California, United States
- Kaiser Permanente Medical Group
San Diego, California, United States
- Stanford Cancer Center
Stanford, California, United States
- Kaiser Permanente Medical Center
Vallejo, California, United States
- University of Coloradohealth Science Center
Aurora, Colorado, United States
- Rocky Mountain Cancer Center-Midtown
Denver, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Hematology Oncology, Pc
Stamford, Connecticut, United States
- Delaware Clinical & Laboratory Physicians, Pa
Newark, Delaware, United States
- University of Miami Medical School
Miami, Florida, United States
- Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
- Gulf Coast Oncology
St. Petersburg, Florida, United States
- H Lee Moffitt Cancer Center
Tampa, Florida, United States
- the Palm Beach Cancer Institute
West Palm Beach, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University Med Ctrdivision of Hem/onc
Chicago, Illinois, United States
- Rush Cancer Institute
Chicago, Illinois, United States
- Indiana Univ Cancer Center Bone Marrow Transplantation Program Indiana Cancer Research Institute
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Wichita Ccop
Wichita, Kansas, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- University of Maryland Medical Center Greenbaum Cancer Ctr
Baltimore, Maryland, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Jackson Oncology Associates
Jackson, Mississippi, United States
- Siteman Cancer Center
St Louis, Missouri, United States
- Deaconess Billings Clinic
Billings, Montana, United States
- Methodist Cancer Center
Omaha, Nebraska, United States
- Nevada Cancer Center
Las Vegas, Nevada, United States
- Dartmouth Hitchcock Medical Center-Norris Cotton Cancer Center
Lebanon, New Hampshire, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 31 Dec 2008
- Completion
- 30 Apr 2009
- Last update posted
- 16 Mar 2010
- Registered enrollment
- 1,913
- Registry id
- NCT00179647
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.